Treating cancer with amplitude-modulated electromagnetic fields: a potential paradigm shift, again?

The Zimmerman et al (2012) study published here, coupled with the group's two preceding papers ( Barbault et al, 2009 ; Costa et al, 2011 ), identify a potential modality for treating tumours at a dramatic reduction in trauma and cost. This set of clinical and explanatory laboratory results should be understood in the context of the history of research into the biological effects of electromagnetic fields (EMFs).